跳至主要内容
临床试验/IRCT20220902055853N1
IRCT20220902055853N1已完成3 期

The Effect of Co-supplementation of Curcumin and Amla on lipid profile, Glycemic status, Antioxidant Indices, Inflammatory Factor, and Liver Enzymes in Patients with Type 2 Diabetes: A Double-Blind Randomized Clinical Trial

Ahvaz University of Medical Sciences0 个研究点目标入组 50 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
25 years 至 65 years(—)
性别
All

入选标准

  • Individuals who are diagnosed with T2DM for at least one years ago
  • Age range from 25 to 65 years
  • BMI range between 25 to 34.9 kg/m2
  • Taking oral blood sugar lowering drugs to control diabetes
  • Consent to participate in the study

排除标准

  • Having chronic diseases (liver, kidney, heart, thyroid, rheumatic, pulmonary, metabolic, digestive, malignancies, allergies)
  • Insulin treatment
  • Taking food supplement, vitamin and mineral for at least in the last 3 months
  • Taking other medicinal plants routinely for at least in the last 3 months
  • Having a weight loss diet for at least in the last6 months
  • Taking drugs or alcohol in the last 6 months
  • Taking steroid anti-inflammatory drugs and fiber supplements
  • Participate in another trial at the same time

研究者

相似试验